Trials / Completed
CompletedNCT00146822
REFLEx Study (ENDOTAK RELIANCE G Evaluation of Handling and Electrical Performance
ENDOTAK RELIANCE G Evaluation of Handling and Electrical Performance Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,500 (planned)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The REFLEx Study will evaluate if ENDOTAK RELIANCE G defibrillation leads with GORE ePTFE-covered coils are as good as or better than other comparative commercially available defibrillation leads with respect to electrical performance and termination efficacy in spontaneous tachyarrhythmic episodes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ENDOTAK RELIANCE G lead |
Timeline
- Start date
- 2004-02-01
- Completion
- 2006-03-01
- First posted
- 2005-09-07
- Last updated
- 2017-02-06
Source: ClinicalTrials.gov record NCT00146822. Inclusion in this directory is not an endorsement.